A recent #JACCAdvances study found that higher levels of cardiac biomarkers could predict a higher risk of cancer. @HealthDayTweets highlights the findings:

A new study shows blood pressure management could reduce dementia risk. “This work highlights the important role of team-based care in chronic disease management,” Joseph Ebinger, MD, a member of #ACCPrev, told @healthcentral.

The @US_FDA has approved new labeling for 2 mRNA #COVID19 vaccines that highlights the risk of #Myocarditis and pericarditis. “I think the more information that we have in the hands of prescribers, and cardiologists, the better,” ACC’s chief medical officer @DickKovacs told.

According to a new study in #JACCIMG, a CAC score of 0 in older adulthood is associated with a favorable mid- to late-life average risk factor profile. Learn more in @CardioAdvisor:

New research suggests women are less likely than men to receive DCD #Hearttx. Find out more:

ACC published a new scientific statement in #JACC on the management of obesity for #HeartFailure patients. Find out more: @CardiologyToday @ScottBuzby.

A new polymer heart valve is linked to positive 1-year outcomes in patients undergoing SMVR, according to a new study in #JACC. @CardioBusiness reports on the findings:

According to new research, women with severe native #vhdAS had significantly better results from surgery with aortic annular enlargement than #TAVR. Find out more:

Among middle-aged athletes, increases in cardiac troponin after aerobic exercise was not linked to subclinical #cvCAD, according to a recent study in #JACC. Learn more about the findings in @TCTMD:

ACC has published new guidance in #JACC on weight management drugs such as semaglutide and tirzepatide. Learn more about the latest Concise Clinical Guidance document with @CardioBusiness:

In a new Concise Clinical Guidance document in #JACC, ACC informs use of popular GLP-1 and GIP medications to reduce CV risk. Find out more with @medpagetoday:

A recent #JACCINT study found transcatheter tricuspid valve replacement with the Evoque system is linked to positive real-world outcomes. Learn more with @CardioBusiness:

Research shows patients w/ acute ischemic #Stroke and without indication for oral #cvCoag shouldn’t be treated w/ the combination of oral anticoagulation w/ antiplatelet therapy. Get the details with @CardioAdvisor:

Coronary #Atherosclerosis is not to blame for cardiac troponin increases after exercise among middle-age athletes, according to an analysis in #JACC. @nicolejlou highlights the findings in @medpagetoday:

ACC has issued a Concise Clinical Guidance document in #JACC on weight management drugs. The document informs use of popular GLP-1 and GIP medications to reduce cardiovascular risk. @mnamponsah discusses the latest guidance in @business:

🔥A record-breaking heatwave has raised alarms across the Midwest and Mid-Atlantic regions in the U.S., increasing the risk of cardiac deaths. ICYMI: A study in #JACC found that heart-related deaths are significantly higher during compound heatwaves. Find out more:.

ACC is hosting a #HealthEquity Summit for leaders across cardiology and a program for young scholars from @aaipdocs’ National Native American Youth Initiative to ensure the most vulnerable populations are receiving life-saving #CVD prevention education and treatments. Learn

Long-term exposure to wildfire smoke may increase the risk of #HeartFailure, especially in older adults, women and vulnerable populations, according to a study published in #JACC. Learn more about the findings:

ACC has issued a Concise Clinical Guidance document to aid clinicians in the use of medication for weight management in patients where treatment may provide cardiovascular benefit. The new guidance is published in #JACC. Get the details:

According to new research, #TAVR patients with moderate to severe #vhdTR could have increased risks of death or #HeartFailure readmission. Learn more with @CardioBusiness: